Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice

Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice

Diabetes mellitus (DM) is one of the major causes of death in the world. There are two types of DM—type 1 DM and type 2 DM. Type 1 DM can only be treated by insulin injection whereas type 2 DM is commonly treated using anti-hyperglycemic agents. Despite its effectiveness in controlling blood glucose...

Full description

Bibliographic Details
Main Authors: Zakiyatul Faizah, Bella Amanda, Faisal Yusuf Ashari, Efta Triastuti, Rebecca Oxtoby, Anny Setijo Rahaju, M. Aminudin Aziz, Maria Inge Lusida, Delvac Oceandy
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Molecules
Subjects:
diabetes mellitus
MST1/2
Hippo pathway
XMU-MP-1
Online Access:https://www.mdpi.com/1420-3049/25/19/4381

Internet

https://www.mdpi.com/1420-3049/25/19/4381

Similar Items